What’s the current market cap for Aegon stock?

Aegon (AEG) has a market cap of $13bn as of June 06, 2026.

What is the P/E ratio for Aegon stock?

The price to earnings (P/E) ratio for Aegon (AEG) stock is 12.04 as of June 06, 2026.

Does Aegon stock pay dividends?

Yes, the Aegon (AEG) stock pays dividends to shareholders. As of June 06, 2026, the dividend rate is $0.375 and the yield is 4.57%. Aegon has a payout ratio of 67.86% on a trailing twelve-month basis.

When is the next Aegon dividend payment date?

The next Aegon (AEG) dividend payment is scheduled for July 06, 2026.

What is the beta indicator for Aegon?

Aegon (AEG) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Aegon stock | $AEG Share Price

13:30

15:10

16:45

18:25

20:00

About Aegon

Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. In recent years, Aegon has been moving through an extensive transformation program during which management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle capital into capital-light and more predictable strategic businesses.

Ticker

$AEG

Sector

Finance

Primary listing

NYSE

Employees

15,304

Headquarters

Schiphol, Netherlands

Website

www.aegon.com

Aegon Metrics

BasicAdvanced

$13bn

12.04

$0.68

0.63

$0.38

4.57%

What the Analysts think about Aegon

Analyst ratings (Buy, Hold, Sell) for Aegon stock.

Bulls say / Bears say

Operating profit increased 11% to €858 million in H2 2025, beating consensus expectations of €842 million and showcasing strong core business performance despite ongoing transformation initiatives.

Transamerica's individual life new sales jumped 49% versus the prior year in H2 2025, led by final expense and indexed universal life products, demonstrating robust growth in its main U.S. market.

Aegon unveiled a €400 million share buyback for 2026 and a plan to move its headquarters to the U.S. and rebrand as Transamerica Inc., demonstrating management’s confidence in its pivot towards higher-growth, capital-light businesses.

Net profit fell sharply to €375 million in H2 2025 as Aegon absorbed €193 million in reinsurance losses, €75 million in fair value losses, and €110 million in relocation and legal costs, pointing to significant volatility from its transformation.

In the U.K., workplace platform net deposits plunged 86% to £273 million and adviser platform net outflows grew to £1.97 billion in H2 2025, signaling persistent challenges in key markets outside the U.S.

Operating capital generation was €267 million in Q1 2026, below the consensus estimate of €275 million, raising concerns about Aegon's ability to maintain its targeted capital generation pace.

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.

Aegon Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Aegon Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AEG

Capital at risk

Market closedADR

Upcoming events

Bulls say / Bears say

Transamerica's individual life new sales jumped 49% versus the prior year in H2 2025, led by final expense and indexed universal life products, demonstrating robust growth in its main U.S. market.

Operating capital generation was €267 million in Q1 2026, below the consensus estimate of €275 million, raising concerns about Aegon's ability to maintain its targeted capital generation pace.

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.